Search Results
Oct 06, 2025, 08:00 ET Atossa Therapeutics Streamlines EVANGELINE Breast Cancer Clinical Trial to Prioritize for 2026 NDA-Enabling Activities
comparators in similar settings report a 41% response rate with tamoxifen and a 78% response rate with an aromatase inhibitor and OFS (Nitz UA, et al., J Clin Oncol. 2022 Aug 10;40(23):2557-2567). However, no efficacy conclusions can be drawn from the ongoing study at this point. There is no change to
More news about: Atossa Therapeutics Inc
Oct 02, 2025, 20:01 ET GORDON & MACPHAIL DÉVOILE LE DESIGN DE LA CARAFE « ARTISTRY IN OAK » PAR LA CÉLÈBRE ARCHITECTE JEANNE GANG POUR LE PLUS ANCIEN SINGLE MALT SCOTCH WHISKY DU MONDE
verre suspendu qui contient le liquide ambré distillé à l'origine dans la distillerie Glenlivet. Les branches ont été conçues en chêne américain, un clin d'œil au bois utilisé dans le tonneau Gordon & MacPhail qui a abrité le spiritueux pendant 85 ans. «
More news about: Gordon & MacPhail
Oct 01, 2025, 09:08 ET NCCN Awards Funding to Improve Care for People with Breast Cancer
NCCN.org for more information. 1 Siegel, R.L., et al., Cancer statistics, 2025. CA Cancer J Clin, 2025. 75(1): p. 10-45. Media Contact: Rachel Darwin
More news about: National Comprehensive Cancer Network
Oct 01, 2025, 08:47 ET Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates
vaginosis: summary of evidence reviewed for the 2021 Centers for Disease Control and Prevention sexually transmitted infections treatment guidelines. Clin Infect Dis. 2022;74:Suppl_2:S144-S151. Vodstrcil L, Plummer E, Fairley C, Hocking, Law M, Petoumenos
More news about: Evofem Biosciences, Inc.
Oct 01, 2025, 07:30 ET Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars
Francis K, Alvrtsyan H, Million RP, Liede A. Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States. Clin Epidemiol. 2015 Jul 17;7:335-45.4 Moffitt Cancer Center. "Bone Metastasis." Accessed: September 14, 2025.
More news about: Biocon Biologics
Sep 30, 2025, 17:23 ET Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)
https://data.worldbank.org/indicator/SP.POP.TOTL Kolkhir P, Muñoz M, Asero R, et al. Autoimmune chronic spontaneous urticaria. J Allergy Clin Immunol. 2022;149(6):1819-1831. doi:10.1016/j.jaci.2022.04.010 Kolkhir, P., Giménez-Arnau, A.M., Kulthanan, K. et al.
More news about: Novartis Pharmaceuticals Corporation
Sep 25, 2025, 18:39 ET Lilly's Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease
Meaningful clinical changes in Alzheimer disease measured with the iADRS and illustrated using the donanemab TRAILBLAZER-ALZ study findings. Neurol Clin Pract. 2023;13(2):e200127. doi:10.1212/CPJ.0000000000200127Sims JR, Zimmer JA, Evans CD, et al. Donanemab in Early Symptomatic
More news about: Eli Lilly and Company
Sep 25, 2025, 14:01 ET U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
Siegel RL, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. 6. American Cancer Society. Cancer Statistics Center. http://cancerstatisticscenter.cancer.org.
More news about: Eli Lilly and Company
Sep 25, 2025, 08:00 ET National Ataxia Foundation Partners with Biogen to Bring Bill Nye "the Science Guy" Back To the Lab With New Series About Friedreich Ataxia
https://pmc.ncbi.nlm.nih.gov/articles/PMC7397644/#Sec9 Wallace SE, Bird TD. Molecular genetic testing for hereditary ataxia: what every neurologist should know. Neurol Clin Pract. 2018;8(1):27-32.
More news about: National Ataxia Foundation
Sep 25, 2025, 08:00 ET Vanda Pharmaceuticals announces the publication in PLOS One of an article titled "Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial"
Washington (DC): National Academies Press (US). 2006.Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007;3(5 Suppl):S7-10. pmid:17824495About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical
More news about: Vanda Pharmaceuticals Inc.
Sep 25, 2025, 08:00 ET Introducing SwimClub™: The First Clinically-Formulated Male Fertility Supplement
ReferencesLevine H, et al. Human Reproduction Update. 2017.Travison TG, et al. J Clin Endocrinol Metab. 2020.Martin JA, et al. National Vital Statistics Reports. 2019.Safarinejad MR. Biol Trace Elem Res.
More news about: Squared Circles
Sep 25, 2025, 05:00 ET Allergan Aesthetics to Showcase Multimodal Treatment Approach and Continued Commitment to Skin Quality at AMWC Dubai
appearance. The term 'skin quality' encompasses this collection of desired outcomes. References: Chiu A et al. Clin Cosmet Investig Dermatol. 2023;16:1521–32.Allergan Aesthetics. Data on File. Consumer Filler. March 2021.Allergan Aesthetics. Data
More news about: AbbVie
Sep 23, 2025, 09:30 ET Lung Cancer Research Foundation and Oncology Advocates United for Climate and Health - International Announce New Research Collaboration
to air pollution has increased by nearly 30% since 2007, as smoking has decreased and air pollution has increased (Turner MC et al, CA Cancer J Clin, 2020). The International Agency for Research on Cancer (IARC) has classified outdoor air pollution and particulate matter (PM) with a diameter of
More news about: Lung Cancer Research Foundation
Sep 23, 2025, 09:00 ET O Positiv Expands Menopause Line with MENO Healthy Aging Collagen & Protein Powder
Sales 12 weeks ending 12/29/24Volpi E, Nazemi R, Fujita S. Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care. 2004 Jul;7(4):405-10. doi: 10.1097/01.mco.0000134362.76653.b2. PMID: 15192443; PMCID: PMC2804956.
More news about: O Positiv Health
Sep 23, 2025, 05:00 ET Allergan Aesthetics Announces Expansion of SKINVIVE by JUVÉDERM® into 35 New Markets, Reinforcing its Commitment to Advancing Global Skin Quality
Living your best skin: Key insights from the 'language of skin' report. REF-130722. October 2024.Niforos F et al. Clin Cosmet Investig Dermatol. 2019;12:791–798.Allergan Aesthetics. Unpublished data. SKINVIVE™ by JUVÉDERM®– 9-month duration of skin hydration
More news about: AbbVie
Sep 22, 2025, 07:45 ET Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych Congresses
2013;14(6):488-492.Billiard M, Sonka K. Idiopathic hypersomnia. Sleep Med Rev. 2016;29:23-33.Trotti LM. Idiopathic hypersomnia. Sleep Med Clin. 2017;12(3):331-344.American Academy of Sleep Medicine. The International Classification of Sleep Disorders. Third Edition (ICSD-3). 2014.Khan
More news about: Jazz Pharmaceuticals plc
Sep 19, 2025, 06:01 ET Innovent Announces Mazdutide Received Approval from China's NMPA for Glycemic Control in Adults with Type 2 Diabetes
and country-level diabetes prevalence estimates for 2021 and projects for 2045 [published correction appeals in Diabetes Res Clin Pract. 2023 Oct; 204: 110945]. Diabetes Res Clin Pract. 2022; 183: 109119. doi: 10.1016/j.diabres.2021. 109119
More news about: Innovent Biologics
Sep 19, 2025, 05:28 ET DarwinCell Showcases novel MSC-based drug ALT001 at the 150th American Neurological Association Annual Meeting
nt[J]. Curr Opin Neurol. 2020; 33(5):641- 648. [5]Talbott EO, Malek AM, Lacomis D. The epidemiology of amyotrophic lateral sclerosis. *Handb Clin Neurol*. 2016;138: 225-238.
More news about: Darwincell Biotech
Sep 18, 2025, 09:00 ET MyOme Expands Rare Disease Test with New Genome Insights
https://ojrd.biomedcentral.com/articles/10.1186/s13023-022-02299-5Paulson HL. Repeat expansion diseases. Handb Clin Neurol. 2018.American Academy of Pediatrics (AAP). Clinical Genetic Evaluation of Children With Global Developmental Delay and Intellectual
More news about: MyOme, Inc
Sep 17, 2025, 07:32 ET Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya™ and Aukelso™, Denosumab Biosimilars
Liede A. Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States. Clin Epidemiol. 2015 Jul 17;7:335-45.4 Moffitt Cancer Center. "Bone Metastasis." Accessed: September 14, 2025.
More news about: Biocon Biologics
Sep 17, 2025, 07:00 ET Insightec's Incisionless Focused Ultrasound Therapy Successfully Treats Downton Abbey Creator Lord Julian Fellowes for Essential Tremor
Accessed: August 2025.5 Gupta et al. Exploring essential tremor: Results from a large online survey. Clin Park Relat Disord. 2021 Jun 25;5:100101.6 Based on 2023 MedScout claims data on patient population and DBS volumes combined with
More news about: Insightec
Sep 17, 2025, 07:00 ET BIMZELX® (bimekizumab-bkzx) Data in Moderate-to-Severe Plaque Psoriasis at EADV Showed Complete Skin Clearance Sustained Over Four Years
report. Br J Dermatol. 2017;177(1):e4-e7. 12. Ogdie A, Weiss P. The Epidemiology of Psoriatic Arthritis. Rheum Dis Clin North Am. 2015;41(4):545–68.13. Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis
More news about: UCB
Sep 16, 2025, 21:38 ET Probiotik dari Air Susu Ibu yang telah Teruji secara Klinis, LC40®, Mendukung Kesehatan Bayi dan Ibu Menyusui
Hurtado et al. Breastfeed Med. 1 Mei 2017; 12(4): 202–209[2] Maldonado-Lobon et al. Breastfeed Med 2015. 10(9):425-32[3] Arroyo et al Clin Infect Dis. 2010 Jun 15;50(12):1551-8
More news about: Kerry Group
Sep 16, 2025, 09:00 ET Insightec's Incisionless Focused Ultrasound Therapy Successfully Treats Downton Abbey Creator Lord Julian Fellowes for Essential Tremor
Accessed: August 2025.5 Gupta et al. Exploring essential tremor: Results from a large online survey. Clin Park Relat Disord. 2021 Jun 25;5:100101.6 Based on 2023 MedScout claims data on patient population and DBS volumes combined with
More news about: Insightec
Sep 16, 2025, 04:26 ET 임상적으로 입증된 모유 유래 프로바이오틱 LC40®, 영유아와 모유 수유 산모 건강 지원
2017 May 1; 12(4): 202–209[2] Maldonado-Lobon et al. Breastfeed Med 2015. 10(9):425-32[3] Arroyo et al Clin Infect Dis. 2010 Jun 15;50(12):1551-8
More news about: Kerry Group